To ascertain if CXCL14 is released by tumour cells, HepG2 and PLC/PRF/5 cells were treated with varying concentrations of anlotinib for 48 h, after which both mRNA and protein levels of CXCL14 were evaluated in the tumour cells and their culture supernatants. This evidence concerns the gene CXCL14 and neoplasm.